Home
Conditions
Multiple Sclerosis, Relapsing-Remitting

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

169 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

NCT05080270

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Servicios Medicos UCC, S.C. Tijuana, Estado de Baja California, Mexico

View Trial Details

Completed

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

NCT02746744

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: South Älvsborg Hospital Borås, Sweden

Falun Hospital Falun, Sweden

Gävle Hospital Gävle, Sweden

Saghlgrenska Hospital Gothenburg, Sweden

View all 17 locations

View Trial Details

Completed

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

NCT02744222

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: State Budgetary Healthcare Institution of Nizhny Novgorod region " "Regional Clinical Hospital N.A. Semashko, Nizhny Novgorod" Nizhny Novgorod, Russia

View Trial Details

Completed

Tecfidera and the Gut Microbiota

NCT02471560

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Research site Drammen, Norway

Research site Haukeland, Norway

Research Site Lillehammer, Norway

Research site Lørenskog, Norway

View Trial Details

Completed

Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients

NCT01417312

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Franz-Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrueck Center for Molecular Medicine Berlin, Germany

View Trial Details

Completed

Cortical Lesions in Patients With Multiple Sclerosis

NCT03653585

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations: Danish Research Centre for Magnetic Resonance Hvidovre, Denmark

View Trial Details

Completed

The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial

NCT04833673

Conditions: Anxiety Disorders, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +25 more
Locations: Hacettepe University Ankara, None Selected, Turkey (Türkiye)

View Trial Details

Completed

Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

NCT03561402

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +7 more
Locations: Department of Pathology Montreal, Quebec, Canada

View Trial Details

Completed

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis

NCT02403570

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations: Division of Clinical Neurosciences, Turku University Hospital Turku, Finland

View Trial Details

Completed

Photobiomodulation Therapy in Persons With Multiple Sclerosis

NCT03691766

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Marquette University Milwaukee, Wisconsin, United States

View Trial Details

Multiple Sclerosis, Relapsing-Remitting

Multiple Sclerosis, Relapsing-Remitting trial results

Related conditions